* Defined as having a continuous episode that is sustained beyond 7 days documented via consecutive ECG recordings, or
* Defined as having a continuous episode that is sustained beyond 7 days documented by an ECG recording and one doctor note indicating the patient had symptoms consistent with AF
* Age 18 through 80 years old
* Failure or intolerance of at least one Class I or III antiarrhythmic drug
* Subject is able and willing to consent to participate in the study and will commit to completion of all follow-up requirements
Exclusion Criteria:
* Longstanding persistent AF, defined as continuous AF greater than 12 month duration
* Left atrial diameter greater than 5.0 cm
* Active systemic infection
* History of thromboembolic event within the past 6 months or evidence of intracardiac thrombus at the time of the procedure
* Prior left atrial ablation attempt, with exception of:
* Any pulmonary vein isolation attempt to treat AF, or
* Successful ablation to treat Wolff-Parkinson White syndrome
* History of left atrial tachycardia
* History of cardiac ablation within 90 days of planned clinical study procedure
* Planned concomitant ventricular ablation
* Cryoglobulinemia
* Structural heart disease of clinical significance including:
* NYHA Class IV Heart Failure
* Diagnosed with NYHA Class III Heart Failure for more than six months at time of the study ablation procedure
* LVEF less than 35%
* Any cardiac surgery (e.g. CABG) within 3 months of the ablation procedure
* Any mechanical heart valve, prior aortic or tricuspid valve replacement (e.g. valvotomy, valve replacement), or tricuspid valve repair
* Severe mitral valve regurgitation or stenosis
* Significant congenital anomaly or anatomy unable to accommodate device
* Prior surgical maze procedure
* Unstable angina
* Myocardial infarction within 3 months of the ablation procedure
* Presence of primum or secundum atrial septal defect
* Anomalous pulmonary venous return
* Prior surgery for congenital heart disease, including atrial septal defect repair
* Hypertrophic cardiomyopathy with LV septal wall thickness \>1.5 cm
* Uncontrolled hyperthyroidism
* Thrombocytosis, thrombocytopenia (including history of heparin-induced thrombocytopenia)
* Severe comorbidity or poor general physical/mental health that, in the opinion of the investigator, will not allow the subject to be a good study candidate
* History of blood clotting or bleeding abnormalities
* Contraindication to all anticoagulation (e.g. novel oral anticoagulants, heparin or warfarin)
* Pregnant, nursing or planning to become pregnant during study duration
* Enrollment in another clinical trial without prior approval from Medtronic
* Presence or use of left atrial appendage closure device
* Presence of or planned implantation of a pacemaker, implantable cardiac defibrillator, implantable loop recorder or cardiac resynchronization device with permanent lead placement
* Pre-existing hemidiaphragmatic paralysis
* Life expectancy less than one year
* Known drug or alcohol dependency
* Existing pulmonary vein stent(s)
Source : Importé depuis le centre
Cohortes
Thérapie ou Intervention proposée
Cohortes
Nom
Condition médicale
Traitement
État du recrutement
Treatment Arm
Subjects enrolled and treated with ArcticLine Cardiac Cryoablation Catheter
Donnée non disponible
Inconnu
Treatment Arm
État du recrutement
unknown
Subjects enrolled and treated with ArcticLine Cardiac Cryoablation Catheter
Données à jour depuis :
12 février 2025
Description de l'étude
Description de l'étude
Résumé de l'étude
The purpose of the ArcticLine Feasibility Study is to collect preliminary safety and effectiveness data on the ArcticLine Catheter.
Source : Importé depuis le centre
Centres participants
Sites
Centres participants
4
centres
BAYCARE MEDICAL GROUP CARDIOLOGY
Tampa
FLORIDA, UNITED STATES
Recrutement local
État du recrutement:
FERMÉ
MONTREAL HEART INSTITUTE
Montreal
QUEBEC, CANADA
Recrutement local
État du recrutement:
FERMÉ
UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER
Ann arbor
MICHIGAN, UNITED STATES
Recrutement local
État du recrutement:
FERMÉ
UNIVERSITY OF PITTSBURGH MEDICAL CENTER (UPMC)
Pittsburgh
PENNSYLVANIA, UNITED STATES
Recrutement local
État du recrutement:
FERMÉ
Source d'information
Dernière modification :
12 février 2025
Données à jour depuis :
20 fév.
Origine des données :
clinicaltrials.gov